← Back to all trials
Active Not Recruiting
NCT07148765
Use of Wearables Following Cystectomy- Part II
Conditions: Bladder Cancer, Neurogenic Bladder Disorder, Cystectomy
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 50
Sponsor: University of Pittsburgh
Location: UPMC Pittsburgh Pennsylvania
Summary
The goal of this observational study is to learn about the practical considerations for having health care providers respond in real-time to abnormalities detected remotely for patients recovering from cystectomy following discharge from the hospital. Participants will be asked to wear a wearable fitness tracker (e.g., Fitbit) and answer a daily brief questionnaire on their smartphone.
The main question\[s\] the investigators aims to answer are:
* Is it practical to have health care providers respond in real-time to abnormal biomarkers collected using fitness trackers for patients recovering from cystectomy?
* Can we identify early biomarker signatures (e.g. using heart rate, pulse oximetry, respiratory rate, etc.) that can predict adverse events that lead to hospital readmissions?
Participants will
* Set up and use a Fitbit Sense 2 device for up to 2 weeks prior to surgery and again for 30 days following discharge after their surgical hospitalization.
* Download and complete questionnaires in a smartphone application for up to 2 weeks prior to surgery and again for 30 days following discharge after their surgical hospitalization.
* Trigger automated alerts when abnormal biometric data (from the Fitbit device) or concerning survey responses are detected.
* Receive contact from a health care provider within 24 hours of an automated alert being generated.
Eligibility Criteria
Inclusion Criteria:
* English-speaking
* Owns a smartphone
* Scheduled to undergo cystectomy with urinary diversion at a UPMC hospital
Exclusion Criteria:
* No reliable internet access
* Concurrent enrollment in another interventional study that may interfere with outcomes
Source: ClinicalTrials.gov (NCT07148765). StuddyBuddy aggregates publicly available trial information.